Ardsley Advisory Partners’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.98M Buy
+350,000
New +$7.53M 1.04% 31
2025
Q4
Sell
-375,000
Closed -$7.1M 175
2025
Q3
$7.1M Buy
+375,000
New +$6.18M 0.88% 42
2025
Q2
Sell
-350,000
Closed -$4.59M 194
2025
Q1
$4.59M Sell
350,000
-775,000
-69% -$11.5M 0.88% 40
2024
Q4
$15.1M Buy
1,125,000
+22,400
+2% +$361K 2.4% 4
2024
Q3
$23.4M Sell
1,102,600
-178,700
-14% -$3.22M 3.85% 1
2024
Q2
$20.6M Sell
1,281,300
-101,900
-7% -$1.87M 3.02% 6
2024
Q1
$20.6M Buy
1,383,200
+50,400
+4% +$690K 2.95% 8
2023
Q4
$12.2M Buy
+1,332,800
New +$9.2M 1.88% 11

Other funds holding OSCR

Ardsley Advisory Partners's OSCR Position: Q2 2026 in Review

Ardsley Advisory Partners opened a new position in Oscar Health (OSCR) in Q2 2026: 350,000 shares worth $9.98M. The stake represents 1.04% of the portfolio and ranks #31 among its holdings. This is a return to the name: Ardsley Advisory Partners previously reported a position in OSCR as recently as Q3 2025.

Ardsley Advisory Partners first reported a position in OSCR in Q4 2023 and has held it in 8 quarters since. The position peaked at $23.4M in Q3 2024. 26 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Ardsley Advisory Partners held 350,000 shares of Oscar Health worth $9.98M as of Q2 2026.
  • Oscar Health was a new Ardsley Advisory Partners position in Q2 2026.
  • Oscar Health made up 1.04% of Ardsley Advisory Partners's portfolio in Q2 2026, its #31 holding.
  • Ardsley Advisory Partners first reported a position in Oscar Health in Q4 2023 and has held it in 8 quarters since.
  • Ardsley Advisory Partners's Oscar Health position peaked at $23.4M in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Ardsley Advisory Partners's 13F filing for Q2 2026, filed 13 Jul 2026.